Achillion Pharmaceuticals Analysis
Achillion Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Achillion Pharmaceuticals pink sheet analysis is to determine its intrinsic value, which is an estimate of what Achillion Pharmaceuticals is worth, separate from its market price. There are two main types of Achillion Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Achillion Pharmaceuticals pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Achillion |
Achillion Pink Sheet Analysis Notes
About 98.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.0. Achillion Pharmaceuticals had not issued any dividends in recent years. Achison Inc. engages in internet advertising through www.dazhong368.com in the New York area. Achison Inc. was incorporated in 2014 and is based in Flushing, New York. Achison is traded on OTC Exchange in the United States.The quote for Achillion Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Achillion Pharmaceuticals please contact the company at 215 709-3040 or go to www.achillion.com.Achillion Pharmaceuticals Investment Alerts
| Achillion Pharmaceuticals is not yet fully synchronised with the market data | |
| Achillion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Achillion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Achillion Pharmaceuticals currently holds 61 K in liabilities with Debt to Equity (D/E) ratio of 1.0, which is about average as compared to similar companies. Achillion Pharmaceuticals has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Achillion Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Achillion Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Achillion Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Achillion to invest in growth at high rates of return. When we think about Achillion Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.7 K. Net Loss for the year was (51 K) with profit before overhead, payroll, taxes, and interest of 7.87 K. | |
| Achillion Pharmaceuticals currently holds about 1.44 K in cash with (39.76 K) of positive cash flow from operations. | |
| Roughly 98.0% of Achillion Pharmaceuticals shares are held by company insiders |
Achillion Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Achillion Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Achillion Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Achillion Pharmaceuticals Outstanding Bonds
Achillion Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Achillion Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Achillion bonds can be classified according to their maturity, which is the date when Achillion Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ACE INA HLDGS Corp BondUS00440EAH09 | View | |
| ACE INA HLDGS Corp BondUS00440EAQ08 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| ACE INA HLDGS Corp BondUS00440EAW75 | View | |
| ACE INA HLDGS Corp BondUS00440EAV92 | View | |
| ACE INA HLDGS Corp BondUS00440EAS63 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Achillion Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Achillion Pink Sheet
If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |